Press Releases

 Filter by Provider

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / Classover Holdings Inc. (Nasdaq:KIDZ)(Nasdaq:KIDZW) ("Classover" or the "Company"), a leading provider in K-12 educational AI, today announced it is partnering with MiniMax, one of Forbes' "Top 50 AI Companies", to advance a next-generation AI Tutor capable of delivering near-human voice interaction, adaptive reasoning, and real-time emotional intelligence.

Secure Your Mission: LegalMatch Connects Nonprofits to Expert Attorneys for Guidance

Marks Strategic U.S. Capital Markets Milestone

BERN, CH / ACCESS Newswire / November 10, 2025 / LEM Surgical, a leading innovator in hard tissue surgical robotics, today announced the successful completion of the first clinical procedures in the United States utilizing its innovative Dynamis Robotic Surgical System.DynamisDynamis Robotic Surgical System

Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering...

BKV Corporation (“BKV” or the “Company”) (NYSE: BKV), today reported financial and operational results for the third quarter of 2025, including guidance for the fourth quarter of 2025.

Leading investment firms KKR and Arcline Investment Management (“Arcline”) today announced that Arcline has entered into a definitive agreement to acquire Novaria Group (“Novaria” or the “Company”), a leading provider of engineered aerospace components and specialty processes, in a transaction valued at $2.2 billion.

Celsius Holdings, Inc. (Nasdaq: CELH) (“Celsius Holdings” or “the company”) today announced that its Board of Directors has authorized a new share repurchase program under which the company may repurchase up to $300 million of its outstanding common stock.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) for its previously announced license agreement with Freenome. Under the agreement, the Company acquired exclusive rights in the United States to Freenome’s blood-based colorectal cancer (CRC) screening tests. The exclusive license expands Exact Science’s leadership in cancer screening by adding blood-based CRC screening options to its portfolio. Exclusivity remains subject to Freenome’s test receiving first-line FDA approval.

Today, Venture Global, Inc. (NYSE:VG) and Naturgy announced the execution of a new long-term Sales and Purchase Agreement (SPA) for the purchase of 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global for twenty years beginning in 2030. The agreement represents Spain’s first long-term contract for American LNG since Venture Global’s first contract in 2018. To date, Venture Global has supplied Spain with 35 cargoes from its Calcasieu Pass and Plaquemines facilities.

BARK, Inc. (NYSE: BARK) (“BARK” or the “Company”), a leading global omnichannel dog brand with a mission to make all dogs happy, today announced its financial results for the fiscal second quarter ended September 30, 2025.

According to Supply Chain’s Big Bet on AI For Geopolitical Resilience, a new global study from Economist Impact, commissioned by Kinaxis® Inc. (TSX:KXS), while 71% of companies have accelerated AI deployment in response to tariffs, inflation, and geopolitical volatility, a wide gap remains between AI ambition and implementation, according to Economist Impact.

The first patient has been dosed in a first-in-human phase 1 trial evaluating DS3610 in patients with advanced, metastatic or unresectable solid tumors.

908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, today announced it will showcase advances in hybrid quantum technology at SC25, the international conference for high performance computing (HPC), networking, storage and analysis. D-Wave will highlight quantum-HPC integration, impactful customer use cases, and emerging quantum-AI applications, underscoring the company’s leadership in delivering energy-efficient quantum solutions that can drive measurable impact today.

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics through its boron chemistry platform, today announced a collaboration agreement with the global biopharma company GSK to develop new therapies for tuberculosis (TB). As part of this effort, the Gates Foundation will provide a third year of funding to support AN2’s work within the collaboration.

KubeCon + CloudNativeCon North America 2025 – Sysdig, the leader in real-time cloud security, today announced new open source threat investigation and analysis capabilities for Falco, the standard for runtime cloud threat detection used by more than 60% of the Fortune 500. These updates deepen Falco’s ability to integrate with Stratoshark, creating a unified, end-to-end cloud security workload built entirely on open source.

The LYCRA Company, a global leader in innovative and sustainable fiber solutions for the apparel and personal care industries, today announced the official opening of its largest spandex production facility—the LYCRA® fiber (Yinchuan) Plant in Ningxia Province, China. This milestone underscores the company’s continued investment in the Chinese market and highlights its strong commitment to developing localized supply and distribution networks while advancing smart manufacturing upgrades.

monday.com (NASDAQ: MNDY) today reported financial results for its third quarter ended September 30, 2025.

For more than a century, JELL-O molds have held a special place on America’s holiday tables, becoming one of the most recognizable traditions of the season. While Thanksgiving tables are full of love and gratitude there are always a few side dishes everyone expects - but not everyone likes. This year, JELL-O is offering a new colorful twist. Introducing the limited-edition JELL-O “No Thanks” Thanksgiving Molds: Brussels sprouts, cranberry sauce and pecan pie reimagined as playful, jiggly creations that are as fun to look at as they are to eat.

Strong land sales lead record results across all segments, supporting upward revision to full-year guidance; $1.4 billion in condominium pre-sales reinforce Company’s long-term cash-flow outlook

Total Revenues Increased 37% with Record Charging Network Revenue of $56 Million

BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.

Three-year follow-up data from FIREFLY-1 demonstrates durable responses with evidence of clinical stability off treatment, with the potential for retreatment after progression

As previously announced on August 19, 2025, TEGNA Inc. and Nexstar Media Group entered into a definitive agreement, under which Nexstar will acquire all outstanding shares of TEGNA for $22.00 per share in a cash transaction valued at $6.2 billion

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the third quarter ended September 30, 2025. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only. The results of the divested Blade Passenger business have been reclassified as discontinued operations in all periods.

- $169.7 million revenue, up 173.6% year-over-year- $43.0 million adjusted EBITDA, up from negative $7.9 million last year- Expanding and accelerating AI strategy across multiple initiatives- Achieved 41.2 EH/s of self-mining at the end of October, 2025- Commenced SEALMINER A3 mass production- Early SEAL04 samples have demonstrated 6-7 J/TH power efficiency at the chip level under low-voltage, ultra-power saving mode

TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) today reported its financial results for the three and nine months ended September 30, 2025. All figures are expressed in United States dollars, unless otherwise indicated.

In vivo preclinical proof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduction in non-human primates supports EDIT-401’s potential as a best-in-class, one-time therapy

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus" or the "Company") (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that it will report its unaudited financial results for the third quarter 2025 on November 24, 2025, before market opening in the United States.

LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad strategic collaboration in the area of ophthalmology with Eli Lilly and Company (“Lilly”).

LATHAM, N.Y., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, today announced that it expects to generate more than $275 million in liquidity improvement through a combination of asset monetization, release of restricted cash, and reduced maintenance expenses.

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its third quarter 2025 financial results before the markets open on Friday, November 14, 2025.

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, November 10, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in November.

The Club and leading global sports investor form long-term partnership to support continued growth under CEO Miguel Ángel Gil and President Enrique Cerezo

SAN CARLOS, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it is scheduled to participate in a fireside chat at the upcoming Jefferies London Healthcare Conference on November 17, 2025 at 4:30 PM (GMT) and will participate in one-on-one meetings on November 17-18, 2025 in London, UK.

SINGAPORE, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for Bitcoin mining and AI cloud, today announced its unaudited mining and operations updates for October 2025.

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today reported financial and operating results for the third quarter ended September 30, 2025.

(All dollar amounts are expressed in Canadian dollars, unless stated otherwise)

CORNELIUS, N.C. and HOUSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) --  Alpha Modus, Corp. (“Alpha Modus”), the subsidiary of Alpha Modus Holdings, Inc. (NASDAQ:AMOD), today announced today that it has resolved its patent infringement lawsuit against OptiSigns, Inc. The case was concluded on November 4, 2025, when the parties jointly filed a stipulated notice of dismissal confirming that all matters in controversy had been settled.

NEW YORK and AMSTERDAM, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments, today announced positive topline results from the open-label extension (OLE) study of its Phase 2b clinical trial (NCT05870540) of BPL-003 in patients with treatment-resistant depression (TRD). Findings show that a 12 mg dose of BPL-003 administered eight weeks after a 0.3 mg, 8 mg or 12 mg dose of BPL-003 was generally well-tolerated and provided additional rapid, clinically meaningful antidepressant effects, which were sustained for up to eight weeks.

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Organto Foods Inc. (TSX-V: OGO; FSE: OGF0; OTCQX: OGOFF), an integrated provider of organic and specialty produce, has qualified to trade on the OTCQX® Best Market. Organto Foods Inc. upgraded to OTCQX from the OTCQB® Venture Market.

Net Contribution grew by 28% year-over-year to $215 millionAssets Under Administration grew by 76% year-over-year to $20.8 billionFunded accounts grew by 16% year-over-year to 3.73 millionAnnounced a $150 million share repurchase program

CONFERENCE CALL FOR INVESTORS NOVEMBER 12, 2025, AT 11:00 AM EST

NEWMARKET, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that AirBoss Defense Group ("ADG"), AirBoss Manufactured Products’ (“AMP”) defense business, has received an order from the Canadian Department of National Defense (“Canadian DND”) for ADG’s Low Burden Masks (“LBM”), filters and related accessories under the In-Service Support Contract awarded to ADG in 2018 (the “JGSR Contract”). The value of this order is expected to be worth up to US$8.1 million. Deliveries are expected to commence in the first quarter of 2026 and conclude in the first quarter of 2027.

Company welcomes measures in Budget 2025 and new infrastructure investments supporting Canada’s Critical Minerals Strategy

CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company accelerating potential high-impact therapies in autoimmune diseases and cancer, today announced its management team will participate in two upcoming investor conferences and will host a company event at the 2025 American Society of Hematology (“ASH”) Annual Meeting in Orlando, FL.

A secondary analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis, inflammation and steatosis in advanced qF4 MASH patients as measured by artificial intelligence (AI) digital pathology

SEP-479 Selected as Next-Generation Oral PTH1R Agonist Development Candidate

ALMATY, Kazakhstan, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”) (Nasdaq:KSPI) which operates the Kaspi.kz and Kaspi Pay Super Apps in Kazakhstan and owns 66.35% of Hepsiburada in Türkiye, today published its unaudited consolidated IFRS financial results for the quarter and 9 months ended 30 September 2025 (“3Q & 9M 2025”).